We are a national, non-profit organization dedicated to
People in Canada
Living with Psoriasis & Psoriatic Arthritis
Our goal is to improve the lives of people living with psoriasis and psoriatic arthritis by providing current information on research and treatment options.
Current State of the COVID-19 Pandemic for the Psoriasis and Psoriatic Arthritis Community
Dr. Mark Kirchhof, MD, PhD, FRCPC, Head of the Division of Dermatology, Faculty of Medicine, University of Ottawa and The Ottawa Hospital, provides an overview of the current state of knowledge about psoriasis and COVID-19. Research is constantly evolving and the information presented in this webinar reflects the date of its original publication (May 2, 2022).
Do you have psoriatic arthritis (PsA)?
Have you taken guselkumab (Tremfya)? We need your valuable input! This anonymous survey will gather patient perspectives to inform treatment recommendations to the Common Drug Review (CDR). Your valuable patient feedback can help to inform drug review and decision-making on public drug reimbursements.
IMD Health Global
CPN is pleased to be partnered with IMD Health Global (IMD). IMD is focused on health education, providing engaging and informative resources to healthcare providers, patients, and their families via the IMD Health Patient Engagement Platform.
Baring it All
World Psoriasis Day October 29, 2021
Significant numbers of people in Canada with psoriasis and psoriatic arthritis (psoriatic disease) say their condition has a significant impact on work and that they need information and support on a variety of workplace-related topics to help them navigate their accommodation needs.
Virtual Summit: Patients Redefining Health Care in Canada
6th Annual Patients Redefining the Future of Health Care in Canada Summit: COVID 19’s Echo Pandemics
INVISIBLE MAN : a Real Life Psoriasis Story
Thank you to all of our individual donors and to our corporate funders!
We couldn't do it without you.
Do you have any questions or suggestions for us? We would love to hear from you.